| Literature DB >> 21907760 |
Emilie Viennois1, Kevin Mouzat, Julie Dufour, Laurent Morel, Jean-Marc Lobaccaro, Silvère Baron.
Abstract
Liver X receptors (LXR) are members of the nuclear receptor family. As activated transcription factors, their putative association with human diseases makes them promising pharmacological targets because of the large potential to develop ligands. LXR are mainly considered as intracellular cholesterol "sensors" whose activation leads to decreased plasma cholesterol. They also modulate numerous physiological functions: fatty acid synthesis and metabolism, glucose homeostasis, steroidogenesis, immunity, and neurological homeostasis. LXR-deficiency in mouse results in several phenotypes mimicking pathological conditions in humans. This review will be focused on the various natural and synthetic LXR agonists and antagonists. Putative clinical targets including atherosclerosis, diabetes, Alzheimer's disease, skin disorders, and cancer will be covered. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 21907760 DOI: 10.1016/j.mce.2011.08.036
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102